Symlin FDA Approval History
FDA Approved: Yes (First approved March 16, 2005)
Brand name: Symlin
Generic name: pramlintide acetate
Dosage form: Injection
Company: Amylin Pharmaceuticals, Inc.
Treatment for: Diabetes, Type 1, Diabetes, Type 2
Symlin (pramlintide acetate) is an antihyperglycemic drug for use in patients with diabetes treated with insulin.
Development Timeline for Symlin
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.